[3]Immunogenicity and Immune Memory after a Pneumococcal Polysaccharide Vaccine Booster in a High-Risk Population Primed with 10-Valent or 13-Valent Pneumococcal Conjugate Vaccine: A Randomized Controlled Trial in Papua New Guinean Children. Vaccines 2019, ...
背景及目的:23价肺炎球菌多糖疫苗(PPSV23)所产生抗体对于慢性阻塞性肺疾病(COPD)的免疫原性和预防效应存在争议.之前的研究发现,7价多糖蛋白结合疫苗(PCV-7)在健康中老年人中产生的免疫反应强于PPSV23.本研究对这两种疫苗在COPD患者中的免疫应答进行比较.Mark T.Dransfield Moon不详H.Nahm Mei不详Lan K.Han不详...
1、 在创伤后早期,适当的机器通气,维持并保护呼吸功能。 2、 在保证病人氧合与有效通气的前提下,尽可能保留病人少量的自主呼吸,可采用SIMV 或配合PSV 3、调节潮气量(VT),使病人处于轻度呼碱状态【PaCO2 20～30mmHg】 (利于降低脑血流量)
<br/>PPSV-23与PCV-7在慢性阻塞性肺疾病患<br/>者中的免疫应答比较<br/><br/>药物临床研究结果<br/> 背景及目的:替卡格雷是一种直<br/> 接作用于二磷酸腺苷受体P2Y12的可逆<br/> 性口服..
Pneumococcal diseases are a serious threat to humans that can cause both invasive and non-invasive diseases. As a result, vaccination against the bacteria causing such diseases is of utmost importance. Let us look at a comparison between PCV 13 and PPSV
S66 A randomised crossover trial of pressure support ventilation (PSV) versus pressure controlled ventilation (PCV) in stable hypercapnic Chronic Obstructive Pulmonary Disease (COPD)No abstract available.doi:10.1136/thx.2010.150938.17K A Brignall...
S66 A randomised crossover trial of pressure support ventilation (PSV) versus pressure controlled ventilation (PCV) in stable hypercapnic Chronic Obstructive Pulmonary Disease (COPD)doi:10.1136/thx.2010.150938.17Brignall K. A.Murphy P. B.Moxham J....
<5岁的健康或上呼吸道感染儿童中,肺炎球菌携带率可达20%-40%[1],是儿童细菌感染的主要原因之一,也是导致5岁以下儿童死亡的重要原因。WHO估计,2015年中国<5岁儿童肺炎球菌性疾病严重病例21万余例,死亡约7000例;其中肺炎球菌性肺炎严重病例数近20万例,病死率为1%;肺...